BR112013004202A2 - cacacterizacão celular - Google Patents

cacacterizacão celular

Info

Publication number
BR112013004202A2
BR112013004202A2 BR112013004202A BR112013004202A BR112013004202A2 BR 112013004202 A2 BR112013004202 A2 BR 112013004202A2 BR 112013004202 A BR112013004202 A BR 112013004202A BR 112013004202 A BR112013004202 A BR 112013004202A BR 112013004202 A2 BR112013004202 A2 BR 112013004202A2
Authority
BR
Brazil
Prior art keywords
cellular characterization
characterization
cellular
Prior art date
Application number
BR112013004202A
Other languages
English (en)
Portuguese (pt)
Inventor
Hillier Chris
O'brien Vincent
Original Assignee
Sistemic Scotland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sistemic Scotland Ltd filed Critical Sistemic Scotland Ltd
Publication of BR112013004202A2 publication Critical patent/BR112013004202A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809Methods for determination or identification of nucleic acids involving differential detection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6881Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
BR112013004202A 2010-08-23 2011-08-19 cacacterizacão celular BR112013004202A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1014049.9A GB201014049D0 (en) 2010-08-23 2010-08-23 Cell characterisation
PCT/GB2011/001241 WO2012025709A1 (en) 2010-08-23 2011-08-19 Cell characterisation

Publications (1)

Publication Number Publication Date
BR112013004202A2 true BR112013004202A2 (pt) 2019-09-24

Family

ID=42984495

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013004202A BR112013004202A2 (pt) 2010-08-23 2011-08-19 cacacterizacão celular

Country Status (12)

Country Link
US (4) US20130196875A1 (enExample)
EP (1) EP2609217B1 (enExample)
JP (1) JP2013535979A (enExample)
KR (1) KR20140006775A (enExample)
CN (1) CN103403180A (enExample)
AU (1) AU2011294936A1 (enExample)
BR (1) BR112013004202A2 (enExample)
CA (1) CA2847151C (enExample)
GB (1) GB201014049D0 (enExample)
IL (1) IL224888B (enExample)
SG (2) SG190837A1 (enExample)
WO (1) WO2012025709A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013188576A2 (en) * 2012-06-12 2013-12-19 Institute For Systems Biology Complex rna composition of bodily fluids
WO2017160880A1 (en) * 2016-03-14 2017-09-21 Aelan Cell Technologies, Inc. Compositions and methods for the quality control of stem cell preparations
SG11201809902QA (en) * 2016-05-09 2018-12-28 Sistemic Scotland Ltd Functional prediction of cellular functions by means of microrna expression profiling in mesenchymal stem cells
JP6629770B2 (ja) * 2017-01-19 2020-01-15 シスメックス株式会社 細胞の分化状態を評価する方法
JP6918062B2 (ja) * 2017-01-19 2021-08-11 シスメックス株式会社 細胞の分化状態を評価する方法
EP3743531A1 (en) * 2018-01-22 2020-12-02 Sistemic Scotland Ltd Cell contamination assay
WO2020072545A1 (en) * 2018-10-01 2020-04-09 Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center MicroRNA TRANSCRIPTIONAL SIGNATURE (miR-TS) EVALUATION OF STEM CELLS
CN113658636B (zh) * 2021-07-22 2025-08-05 未来智人再生医学研究院(广州)有限公司 一种评估多能干细胞质量的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123952A1 (en) * 2003-09-04 2005-06-09 Griffey Richard H. Methods of rapid detection and identification of bioagents using microRNA
IL179285A (en) * 2004-05-14 2011-04-28 Rosetta Genomics Ltd Micrornas and uses thereof
EP1966390A1 (en) * 2005-12-29 2008-09-10 Exiqon A/S Detection of tissue origin of cancer
CN101316935B (zh) * 2006-11-28 2012-02-29 博奥生物有限公司 一种用于诊断食道癌的芯片
CN101622349A (zh) * 2006-12-08 2010-01-06 奥斯瑞根公司 作为治疗性干预靶标的miR-21调节的基因和途径
WO2008112283A2 (en) * 2007-03-12 2008-09-18 Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Microrna profiling of androgen responsiveness for predicting the appropriate prostate cancer treatment
WO2009036332A1 (en) * 2007-09-14 2009-03-19 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
WO2009062503A1 (en) * 2007-11-14 2009-05-22 Dandrit Biotech A/S Micro rnas as markers of the functional state of a dendritic cell
EP2250496A4 (en) * 2008-02-28 2011-08-31 Univ Ohio State Res Found MICRO-RNA SIGNATURES ASSOCIATED WITH CYTOGENETICS AND PROGNOSIS IN ACUTE MYELOID LEUKEMIA (AML) AND USES THEREOF
US20100003674A1 (en) * 2008-07-03 2010-01-07 Cope Frederick O Adult stem cells, molecular signatures, and applications in the evaluation, diagnosis, and therapy of mammalian conditions
KR20110138341A (ko) * 2009-01-19 2011-12-27 시스테믹 스코틀랜드 리미티드 비암호화 rna 발현 검정법을 이용한 방법

Also Published As

Publication number Publication date
US20230183803A1 (en) 2023-06-15
CN103403180A (zh) 2013-11-20
EP2609217A1 (en) 2013-07-03
SG190837A1 (en) 2013-07-31
JP2013535979A (ja) 2013-09-19
EP2609217B1 (en) 2019-03-27
SG10201506595QA (en) 2015-10-29
US20170218446A1 (en) 2017-08-03
KR20140006775A (ko) 2014-01-16
CA2847151C (en) 2023-11-28
WO2012025709A1 (en) 2012-03-01
CA2847151A1 (en) 2012-03-01
US20200080148A1 (en) 2020-03-12
GB201014049D0 (en) 2010-10-06
AU2011294936A1 (en) 2013-04-11
US20130196875A1 (en) 2013-08-01
IL224888B (en) 2020-10-29

Similar Documents

Publication Publication Date Title
BR112013014486A2 (pt) amortecimento celular interpontualizado
DK2646647T3 (da) Frakturkarakterisering
DK3053932T3 (da) Hidtil ukendte ctla4-ig-immunoadhesiner
DK2536830T3 (da) Polypeptider
IL226437A0 (en) Dosage form
UA21667S (uk) Телефон мобільний
EP2661055A4 (en) MOBILE PHONE
IL225897A0 (en) Cxcr2 binding polypeptides
EP3525531C0 (en) MULTIPLE SIM MANAGEMENT
FI20105284L (fi) Sekoitin
EP2730040A4 (en) RADIO TRANSMISSION TEST
EP2579281A4 (en) REACTOR
EP2396853A4 (en) ANTENNA
EP2571756A4 (en) RADOM
ES2609638T8 (es) Poración celular
DK3372070T3 (da) Pattekop-gummi
FI20095085A0 (fi) Moniresonanssiantenni
BR112013004202A2 (pt) cacacterizacão celular
ES1078048Y (es) Proyector de celular
EP2532472A4 (en) MOBILE WORKBENCH
FI20095830A0 (fi) Tukivaljaat
FI20086252A0 (fi) Radiovastaanotin
EP2623103A4 (en) PLASTER
EP2451006A4 (en) PORTABLE RADIO
ITGE20110047A1 (it) Miscelatore

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.